146 related articles for article (PubMed ID: 29862278)
1. Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma.
Sun Q; Li F; Yu S; Zhang X; Shi F; She J
Biomed Res Int; 2018; 2018():6135016. PubMed ID: 29862278
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.
Zhou J; Shen W; He X; Qian J; Liu S; Yu G
Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
4. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
[TBL] [Abstract][Full Text] [Related]
5. Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.
Li C; Li X; Wu L; Jiang Z
Technol Cancer Res Treat; 2017 Aug; 16(4):421-427. PubMed ID: 27143047
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of PIWIL2 in hilar cholangiocarcinoma tissues and cell lines.
Chen YJ; Xiong XF; Wen SQ; Tian L; Cheng WL; Qi YQ
Genet Mol Res; 2015 Jun; 14(2):7053-61. PubMed ID: 26125915
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival.
Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z
PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257
[TBL] [Abstract][Full Text] [Related]
8. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
Lederer A; Herrmann P; Seehofer D; Dietel M; Pratschke J; Schlag P; Stein U
Hepatology; 2015 Sep; 62(3):841-50. PubMed ID: 25953673
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Li O; Yi W; Yang P; Guo C; Peng C
Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
Sun Q; Li F; Sun F; Niu J
Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
[TBL] [Abstract][Full Text] [Related]
12. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
13. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
[TBL] [Abstract][Full Text] [Related]
14. AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.
Mikesch JH; Hartmann W; Angenendt L; Huber O; Schliemann C; Arteaga MF; Wardelmann E; Rudack C; Berdel WE; Stenner M; Grünewald I
Cell Oncol (Dordr); 2018 Aug; 41(4):455-462. PubMed ID: 29873033
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma.
Xu D; Yi W; Chen Y; Ma L; Wang J; Yu G
Med Oncol; 2014 Dec; 31(12):261. PubMed ID: 25344871
[TBL] [Abstract][Full Text] [Related]
16. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.
Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G
BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401
[TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ6 predicts poor prognosis and promotes resistance to cisplatin in hilar cholangiocarcinoma.
Sun Q; Dong X; Shang Y; Sun F; Niu J; Li F
Pathol Res Pract; 2020 Jul; 216(7):153022. PubMed ID: 32534716
[TBL] [Abstract][Full Text] [Related]
18. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma.
Ye XW; Hu HJ; Xiong XZ; Lu J; Cheng NS
Surg Today; 2021 Aug; 51(8):1352-1360. PubMed ID: 33651221
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of mucinous component in hilar cholangiocarcinoma after curative-intent resection.
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
J Surg Oncol; 2019 Dec; 120(8):1341-1349. PubMed ID: 31612493
[TBL] [Abstract][Full Text] [Related]
20. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]